维普期刊资源整合服务平台（V6.5）

1132篇 您的检索式：作者名="Morrow DA"

选中清除导出查看参考文献查看引证文献引用追踪共57页首页上一页第1页下一页末页 /57 跳转

	题名	作者	年代	出处	被引量
1	Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes 显示文摘	de Limos JA Morrow DA	2003	Rev Cardiovasc Med2003，4，4：	1
2	B-type brain natriuretic peptide and prognosis in patients with ST-segment elevation myocardial infarction:an ENTIRE-TIMI-23 substudy显示文摘	Morrow DA Lemos JA	2004	J Am Coll cardiol2004，44，：	1
3	Vorapaxar in the secondary prevention of atherothrombotic events显示文摘	MORROW DA BRAUNWALD E BONACA MP	2012	N Engl J Med2012，366，15：	1
4	Lipoprotein-asso- ciated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TI- MI 22 ( PRavastatin Or atorVastatin Evaluation and Infection Therapy- Thrombolysis In Myocardial Infarction) trial 显示文摘	O' Donoghue M Morrow DA Sabatine MS	2006	Circulation2006，113，14：	1
5	Multimarker approach to risk stratification in non- ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide显示文摘	Sabatine MS Morrow DA de Lemos JA	2002	Circulation2002，105，15：	1
6	The search for abiomarker of cardiacischemia显示文摘	Morrow DA de Lemos JA Sabatine MS	2003	Clin Chem2003，49，4：	1
7	Elevation of B-type natriuretic peptide in the setting of myocardial ischemia 显示文摘	Sabatine MS Morrow DA de Lemos JA	2001	Circulation2001，104，2：	1
8	TIMI risk score for ST-elevatian myocardial infarction:A convenient,bedside,clinical score for risk assessment at presentation显示文摘	Morrow DA Antman EM Charlesworth A	2000	Circulation2000，102，17：	1
9	C-reactive protein is a potent predictor of mortality independent of and incombination with troponin T in acute coronary syndromes:a TIMI 11A substudy显示文摘	Morrow DA Rifai N Antman EM	1998	J Am Coll Cardiol1998，31，7：	1
10	Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease显示文摘	Sabatine MS Morrow DA Jablonski KA	2007	Circulation2007，115，12：	1
11	Inflammatory biomarkersin acute coronary syndromes partll:acute phase reactants and bio-markersof endothelial cell aclivation显示文摘	Armstrong EJ Morrow DA Sabaline MS	2006	Circulation2006，113，7：	1
12	Inflammatory biomarkers in acute coronary syndromes:part Ⅳ:matrix metalloproteinases and biomarkers of platelet activation显示文摘	Armstrong EJ Morrow DA Sabatine MS		0，，09：	1
13	B-Type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction:an ENTIRE-TIMI-23 substudy显示文摘	Mega JL Morrow DA De Lemos JA	2004	J Am Coll Cardiol2004，44，2：	1
14	Association of hemoglobin levels with clinical outcomes in acute coronary syndromes显示文摘	Sabatine MS Morrow DA GiugIiano AP	2005	Circulation2005，111，16：	1
15	The search for a biomarker of cardiac ischemia显示文摘	Morrow DA de Lemos JA Sabatine MS	2003	Clin Chem2003，49，4：	1
16	Elevations in troponin T and I are associated with abnormal tissue level perfusion:a TACTICS-TIMI 18 substudy显示文摘	Wong GC Morrow DA Murphy S	2002	Circulation2002，106，：	1
17	Serum amy- loid A predicts early mortality in acute coronary syn- dromes: A TIMI 11 A substudy显示文摘	Morrow DA Rifai N Antman EM	2000	J Am Coll Cardiol2000，35，2：	1
18	C-reactive protein,inflammation,and coronary risk显示文摘	Ridker PM Morrow DA	2003	Cardiol Clin2003，21，3：	1
19	Evaluation of B - type natriuretic peptide for risk assessment in unstable angina/non - ST - elevation myocardial infarction: B -type natriuretic peptide and prognosis in TAC- TICS TIMI 18显示文摘	Morrow DA De Lemos JA Sabatine MS	2003	J Am Coll Cardiol2003，41，8：	1
20	National Academy of Clini- cal Biochemistry Laboratory Medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes显示文摘	Morrow DA Cannon CP Jesse RL et a	2007	Clin Chem2007，53，：	1

返回顶部每页显示：

共57页首页上一页第1页下一页末页 /57 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示